Farms.com Home   News

Senate Introduces wheat aid bill to fight hunger

The Senate’s fresh initiative, the American Farmers Feed the World Act, has secured support from the U.S. Wheat Associates (USW) and the National Association of Wheat Growers (NAWG). The legislation’s goal to utilize U.S. wheat to battle global hunger. 

This bipartisan effort champions the Food for Peace program's essence, using homegrown resources instead of buying food from foreign competitors. USW’s Peter Laudeman applauds the act for its emphasis on U.S. participation in food aid. Denise Conover, a Montana wheat farmer and USW board representative, expressed her pride in her farm's contribution to global food relief. 

Brent Cheyne of NAWG underscored the significance of wheat from the U.S., contributing to a fifth of the world's calorie consumption. He believes this act can rejuvenate the dwindling use of American crops in global food aid. Advocating for the benefits of local commodities, Brian Linin pointed out their edge over cash handouts. This act will soon be part of the Farm Bill discussions. 

Source : wisconsinagconnection

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.